Biogen
Cambridge · Founded 1978
About Biogen
Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.
Company Facts
- Founded: 1978
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $1.5B
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2023)
- Ticker: nasdaq:BIIB
- Website: biogen.comen_ushome.html
- Phone: +1 781-464-2000
Industries & Categories
Biotechnology, Health Care, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biogen-79513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.